Please see below for a list of search results.
The HTA was asked to share a letter written to the University of Bristol regarding a process taking place at the university in 2008, as part of a process to create an artificial trachea for transplant
The HTA was asked if there had been any cases of prosecution under the Human Tissue Act, and if so what were the details and outcome of the prosecutions.
The HTA was requested to provide the total staff headcount, in addition to a detailed breakdown of any contracts with temporary worker agencies.
The HTA was requested to provide a detailed breakdown of its ICT expenditure.
The HTA was asked to provide information relating to compromise agreements at the HTA
The HTA was asked to provide information relating to serious adverse events and adverse reactions (SAEARs) in the organ donation and transplantation sector in the year 2015.
The HTA was asked to provide its organisational chart and details on contractor/agency staff.
The HTA was asked who is responsible for our ICT/Digital/Business Change Programmes and Strategy.
As a regulator, transparency is not only an aspiration and value, but a statutory duty under the Human Tissue Act. It is also a priority for the Department of Health and Government more generally.